This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gorrell, R. J. Articles by Bishop, R. F. Search for Related Content PubMed PubMed Citation Articles by Gorrell, R. J. Articles by Bishop, R. F.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 09 1997, 509-514, Vol 4, No. 5
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Production of reassortant viruses containing human rotavirus VP4 and SA11 VP7 for measuring neutralizing antibody following natural infection

RJ Gorrell and RF Bishop
Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Parkville, Victoria, Australia. gastro@cryptic.rch.unimelb.edu.au

The outer capsid proteins VP4 and VP7 of group A rotaviruses are both targets of neutralizing antibody produced following natural infection in humans. Of interest is the relative importance and immunodominance of each protein in the generation of a protective immune response. In order to measure neutralizing antibody responses to VP4 and VP7 separately, reassortants bearing VP4 of each of the major human rotavirus P types with VP7 of SA11 origin were successfully produced by neutralizing monoclonal antibody selection. The resulting reassortants, together with reassortants representing each of the major VP7 types, were antigenically characterized with serotype-specific neutralizing monoclonal antibodies and hyperimmune sera. The neutralization proteins of human rotavirus origin were found to be unaffected antigenically by reassortment. The abilities of these reassortants to discriminate between VP4 and VP7 immune responses were evaluated with postinfection sera collected from three patients infected with either a P1A[8],G1, a P1B[4],G2, or a P1A[8],G4 rotavirus strain. The reassortants were shown to be capable of separating the neutralizing antibody responses to VP4 and VP7, with each patient showing a different immune response with respect to VP4 or VP7 immunodominance. These reassortants can now be applied to analyses of individual immune responses to VP4 and VP7 proteins after primary rotavirus infections and reinfections in humans.

This article has been cited by other articles:

• Ray, P. G., Kelkar, S. D. (2004). Prevalence of Neutralizing Antibodies against Different Rotavirus Serotypes in Children with Severe Rotavirus-Induced Diarrhea and Their Mothers. CVI 11: 186-194 [Abstract] [Full Text]  
• Ciarlet, M., Crawford, S. E., Barone, C., Bertolotti-Ciarlet, A., Ramig, R. F., Estes, M. K., Conner, M. E. (1998). Subunit Rotavirus Vaccine Administered Parenterally to Rabbits Induces Active Protective Immunity. J. Virol. 72: 9233-9246 [Abstract] [Full Text]  
• Menchaca, G., Padilla-Noriega, L., Méndez-Toss, M., Contreras, J. F., Puerto, F. I., Guiscafré, H., Mota, F., Herrera, I., Cedillo, R., Muñoz, O., Ward, R., Hoshino, Y., López, S., Arias, C. F. (1998). . CVI 5: 328-334 [Abstract] [Full Text]